Yüklüyor......
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
The recent spreading of new SARS-CoV-2 variants, carrying several mutations in the spike protein, could impact immune protection elicited by natural infection or conferred by vaccination. In this study, we evaluated the neutralizing activity against the viral variants that emerged in the United King...
Kaydedildi:
| Yayımlandı: | Viruses |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8310013/ https://ncbi.nlm.nih.gov/pubmed/34372553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v13071347 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|